Author:
Fenton Bruce M.,Paoni Scott F.,Grimwood Brian,Ding Ivan
Reference24 articles.
1. P. A. Burke, and S. J. DeNardo, Antiangiogenic agents and their promising potential in combined therapy, Crit. Rev. Oncol. Hematol. 39, 155–171 (2001).
2. J. C. Lee, D. C. Kim, M. S. Gee, H. M. Saunders, C. M. Sehgal, M. D. Feldman, S. R. Ross, and W. M. Lee, Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas, Cancer Res. 62, 747–755 (2002).
3. B. M. Fenton, S. F. Paoni, B. K. Beauchamp, B. Tran, L. Liang, B. Grimwood, and I. Ding, Evaluation of microregional variations in tumor hypoxia following the administration of endostatin, Adv. Exp. Med. Biol. 510, 19–24 (2003).
4. T. Boehm, J. Folkman, T. Browder, and M. S. O’Reilly, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance, Nature 390, 404–407 (1997).
5. C. J. Bruns, M. Shrader, M. T. Harbison, C. Portera, C. C. Solorzano, K. W. Jauch, D. J. Hicklin, R. Radinsky, and L. M. Ellis, Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice, Int. J. Cancer 102, 101–108 (2002).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献